Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$204,607
-$30,759 QoQ
Shares Held
8,497
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,444
of 2,821 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arcataur Capital Management LLC holds $3,137,691 across 5 Drug Manufacturers - General names. PFE ranks #5 (6.5% of the industry book) .
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,607 | 8,497 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $235,366 | 8,382 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $209,707 | 8,422 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $211,789 | 8,312 | Shares | Sole | 2025-10-22 | |
| 2024-12-31 | $210,276 | 7,926 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $232,417 | 8,031 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $224,987 | 8,041 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $223,970 | 8,071 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $232,364 | 8,071 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $261,081 | 7,871 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $288,708 | 7,871 | Shares | Sole | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||